Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Electric grid innovation to medical device monitoring, DNA sequencing, sustainable materials, and clean energy are projected to grow at CAGRs above 20%.
-
San Diego, CA, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The Challenged Athletes Foundation (CAF), a global leader in empowering individuals with physical disabilities through sport, proudly celebrates the...
-
New Westminster, BC, Jan. 22, 2026 (GLOBE NEWSWIRE) -- LifeLabs, Canada's leading provider of medical diagnostic services, has officially opened a new Patient Service Centre (PSC) in Uptown New...
-
Delray Beach, FL, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The global drug discovery mass spectrometry market was valued at USD 0.89 billion in 2024 and is projected to reach USD 1.69 billion by 2031,...
-
NEW YORK e SAVONA, Italia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, una divisione di Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) e leader mondiale nel settore della cannabis...
-
NEW YORK und SAVONA, Italien, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. („Tilray“) (Nasdaq: TLRY; TSX: TLRY) und ein weltweit führender Anbieter...
-
NEW YORK et SAVONE, Italie, 22 janv. 2026 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc. (« Tilray ») (Nasdaq : TLRY ; TSX : TLRY) et leader mondial du cannabis...
-
HAIFA, Israel, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Pluri, Inc. (“Pluri”, the “Company”, “we” or “us”) (Nasdaq, TASE: PLUR), a biotechnology company leveraging its proprietary platform for cell-based...
-
Delray Beach, FL, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The Global orthopedic biomaterials market is projected to reach USD 24.86 billion by 2030 from USD 16.95 billion in 2025, at a CAGR of 8.0% from...
-
CARMEL, Ind., Jan. 22, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel...